[1]
S. Ismailova, “IMPACT OF EMPAGLIFLOZIN ON ENDOTHELIAL FUNCTION IN NON-DIABETIC CHRONIC KIDNEY DISEASE”, AMJ, no. 1, pp. 34–38, Mar. 2025.